Press Releases

Updates arrive automatically.

• New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention

  

  PR12:16:00·6m·Health Care

  New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention

  – Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period – – PURPOSE 5 Study Findings Highlight the Potential of Long-Acting HIV Prevention Option to Address Persistence Challenges with Up to a Full Year of Protection After Second Dose – Gilead Sciences, Inc. (NASDAQ:GILD) today announced results from the PURPOSE 5 trial showing significantly higher persistence—defined as consistent and continuous on-time use—among people starting twice-yearly injectable lenacapavir for HIV prevention as pre-exposure prophylaxis (PrEP), compared with those starting daily oral emtricitabine/tenofovir disoproxil fumarate (F/TDF). The trial incl

  $GILD
• New England Realty Associates LP Announces Fourth-Quarter Distribution on Class A Units and Depositary Receipts

  

  PR12:02:00·20m·Consumer Services

  New England Realty Associates LP Announces Fourth-Quarter Distribution on Class A Units and Depositary Receipts

  On December 31, 2026, New England Realty Associates Limited Partnership (NYSE:NEN) will make its quarterly distribution to its Class A Limited Partners and holders of Depositary Receipts of record as of December 16, 2026. The quarterly distribution per Class A Limited Partnership Unit will be $12.00 per Unit. The quarterly distribution per Depositary Receipt will be $0.40. Each Depositary Receipt represents a beneficial ownership of one-thirtieth of a Class A Partnership Unit. Depositary Receipts are listed on The NYSE MKT under the trading symbol "NEN". View original content:https://www.prnewswire.com/news-releases/new-england-realty-associate

  $NEN
• Solo Stove and Marshawn Lynch encourage gift givers to shop Solo Stove this holiday with their new "Gifts That Don't Suck" campaign

  

  PR12:02:00·20m·Consumer DiscretionaryLow floatPenny stock

  Solo Stove and Marshawn Lynch encourage gift givers to shop Solo Stove this holiday with their new "Gifts That Don't Suck" campaign

  The NFL legend teams up with Solo Stove to help shoppers nail gift season with thoughtful gifts that bring people together long after the holidays.

  $SBDS
• Lifeway® Kefir Commercial Makes Chicagoland Television Debut Sunday, November 8, With New Muscle Mates™ Social Media Campaign to Follow

  

  PR12:00:00·22m·Consumer Staples

  Lifeway® Kefir Commercial Makes Chicagoland Television Debut Sunday, November 8, With New Muscle Mates™ Social Media Campaign to Follow

  Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products, is bringing its partnership with Chicago football stars Colston Loveland and D'Andre Swift to a bigger stage. On Sunday, November 8, Lifeway's humorous kefir commercial featuring the two athletes will make its Chicagoland television debut, expanding the reach of a fan-favorite campaign that first launched exclusively on social media. The broadcast debut will be followed by an all-new, social-exclusive campaign featuring the players promoting Lifeway

  $LWAY
• Northern Trust Pension Universe Data: Canadian Pension Plans Navigate Challenging Markets in Q3

  

  PR12:00:00·22m·Finance

  Northern Trust Pension Universe Data: Canadian Pension Plans Navigate Challenging Markets in Q3

  Canadian pension plan returns fell in the third quarter, mostly a result of rising bond yields, with the median pension plan returning -1.5% for the quarter ending September 30 and 4.4% year-to-date, according to the Northern Trust Canada Universe. Third-quarter financial markets were shaped by the return of energy-driven inflation and a sharp rise in global interest rates. Middle East tensions returned to the foreground, pushing Brent crude oil above $100 per barrel and renewing concerns around inflation and energy supply. The rise in oil occurred against a backdrop of resilient economic activity and generally constructive corporate earnings. After holding rates in July, the U.S. Federal

  $NTRS
• Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026

  

  PR12:00:00·22m·Health CarePenny stock

  Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026

  Meaningful antitumor activity observed at the 3.0 mCi monotherapy dose with 75% disease control rate and durable disease stabilization; one of two confirmed responders remains on study ~40 weeks after the first treatmentNo dose-limiting toxicities, treatment-related serious adverse events, or discontinuations due to adverse events were reported across 20 patients in three monotherapy dose cohorts as of the data cut-off Continued evaluation and dose optimization of lapemelanotide to inform future clinical development

  $CATX
• Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

  

  PR12:00:00·22m·Health Care

  Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

  In 17 first-line patients treated with the combination, the estimated two-year overall survival (OS) rate was 70% - Median OS was not reached at a median follow-up of 29 months and 10 patients remained on study Majority of patients (64%) with an OS over 2 years received only the combination The combination achieved a 29% overall response rate with a median duration of response of 24 months and a 71% disease control rate First data showing clinical activity and manageable safety profile with a combination of two T cell engagers in a solid tumor The Company is planning a Phase 2/3 randomized trial evaluating the combination in unresectable or metastatic uveal melanoma (OXFORDSHIRE, Engla

  $IMCR
• Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

  

  PR11:49:57·32m·TechnologyPenny stock

  Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

  Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Endava (DAVA) To Contact Him Directly To Discuss Their Options If you purchased or acquired Endava securities between September 4, 2025 and September 21, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

  $DAVA
• European Commission approves AkzoNobel and Axalta merger of equals

  

  PR11:45:01·37m·Consumer Discretionary

  European Commission approves AkzoNobel and Axalta merger of equals

  Akzo Nobel N.V. (AKZA; AKZOY) ("AkzoNobel") and Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta") today received conditional approval from the European Commission for their proposed all-stock merger of equals, which will create a premier global coatings company. The transaction is expected to close in early 2027 subject to pending regulatory approvals. Following constructive discussions with the European Commission, AkzoNobel and Axalta have agreed to a targeted remedy involving the divestment of AkzoNobel’s European vehicle refinish business. The commitments offered fully address the preliminary competition concerns identifi

  $AXTA
• Contracted Capacity, Containers on the Water: AZIO AI Moves Atlas One Into Its Equipment Phase

  

  PR11:36:01·46m·Consumer DiscretionaryLow floatPenny stock

  Contracted Capacity, Containers on the Water: AZIO AI Moves Atlas One Into Its Equipment Phase

  Project Atlas One is moving from plans into equipment. AZIO AI Holdings, Inc. (NASDAQ:AZIO) has containers on the water, equipment coming in one step at a time and a phased build coordinated with Texas site partner Texoil Ventures LLC, alongside its signed 10 MW Power Champion contract. Contracted today: Power Champion — 10 MW at $150 per kW per month, or $1.5 million per month at full delivery (about $90 million over 60 months). What is contracted todayToday, the only signed customer contract at Atlas One is AZIO's infrastructure hosting agreement with Power Champion: 10 MW at $150 per kW per month, or $1.5 million per month at full delivery an

  $AZIO
• SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA

  

  PR11:32:00·50m·Consumer Discretionary

  SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA

  Silversea celebrates the opening of the 150-room hotel in Puerto Williams, Chile, with a ribbon-cutting ceremony featuring performances by local children and artists

  $RCL
• West Virginia American Water Advances Central Grove Project as Part of Broader Water System Upgrades

  

  PR11:31:00·51m·Utilities

  West Virginia American Water Advances Central Grove Project as Part of Broader Water System Upgrades

  West Virginia American Water is moving forward with additional upgrades to Jefferson County's water infrastructure with work to prepare the future site of the Central Grove Water Treatment Plant. The project is located near the intersection of Goldenrod Drive and Marie Drive. Initial work includes selective tree clearing, grading, decorative fencing, landscaping improvements, and well evaluation. The new water treatment plant will become part of the larger water system serving the area and represents an important step toward connecting the Mountain and Walnut Grove water systems. The Walnut Grove system already operates as an interconnected ne

  $AWK
• Superior Group of Companies Declares Regular Quarterly Cash Dividend

  

  PR11:30:14·52m·Consumer Discretionary

  Superior Group of Companies Declares Regular Quarterly Cash Dividend

  The Board of Directors of Superior Group of Companies, Inc. (NASDAQ:SGC) today announced that it has declared a quarterly dividend of $0.14 per share, payable November 25, 2026, to shareholders of record as of November 16, 2026. About Superior Group of Companies, Inc. (SGC):Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment

  $SGC
• Hudbay Files Technical Report for its Snow Lake Operations in Manitoba

  

  PR11:30:00·52m·Basic Materials

  Hudbay Files Technical Report for its Snow Lake Operations in Manitoba

  Hudbay Minerals Inc. ("Hudbay" or the "Company") (TSX, (TSX, NYSE:HBM) today announced that, further to the Company’s news release dated September 28, 2026, the Company has filed a National Instrument 43-101 technical report for its Snow Lake operations in Manitoba (the "2026 Technical Report"). Hudbay’s 100% owned Snow Lake operations in Manitoba include the Lalor gold-copper-zinc mine, the New Britannia gold mill, the Stall base metals concentrator, the 1901 zinc-gold deposit, several satellite deposits and the former producing New Britannia gold mine currently on care and maintenance. As disclosed in the September 28, 2026 news release, the h

  $HBM
• Chemed Corporation Declares Quarterly Dividend of 70 Cents

  

  PR11:23:23·59m·Health Care

  Chemed Corporation Declares Quarterly Dividend of 70 Cents

  Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026. This represents the 222nd consecutive quarterly dividend paid by Chemed in its 55 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life

  $CHE
• HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer

  

  PR11:00:00·1h·Health CareLow floatPenny stock

  HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer

  Designated as one of the Top 150 abstracts submitted for the 41st Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class, second-generation, tetravalent pembrolizumab (Keytruda®) based immune checkpoint inhibitor, built with Company’s proprietary non-Fc TRBC platform HCW11-040 was constructed with interleukin domains (IL-15 and IL-7) paired with a TGF-β trap, that in combination can potentially rejuvenate exhausted T cells for more effective cancer cell killing HCW11-040 outperformed immune checkpoint inhibitors in converting immunological cold tumors to hot tumors for solid tumor immunotherapy in preclinical studies MIRAMAR, Fla., Nov. 06, 2026 (GLOBE

  $HCWB
• New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01

  

  PR11:00:00·1h·Health CarePenny stock

  New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01

  Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responsesData further underlines the strong predictive performance of Evaxion’s AI-Immunology™ platformThe new biomarker data supplements recently published three-year data showing 89% vaccine target precision and sustained T-cell and clinical responses COPENHAGEN, Denmark, November 6, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new biomarker data from its phase 2 trial with personalized cancer vaccine EVX-01 in patients with advanced melanoma (skin cancer). The data demons

  $EVAX
• Comcast Co-Founding Partner and Cable Television Pioneer Julian A. Brodsky Dies at 93

  

  PR10:46:00·1h·TelecommunicationsOffering

  Comcast Co-Founding Partner and Cable Television Pioneer Julian A. Brodsky Dies at 93

  Comcast Corporation is saddened to announce the passing of Julian A. Brodsky, a co-founding partner of the company and a pioneer of the cable television industry, on November 5, 2026. He was 93. Together with Comcast founder Ralph J. Roberts and co-founding partner Daniel Aaron, Julian helped build the company from its earliest days, beginning with the acquisition of a small cable television system in Tupelo, Mississippi, in 1963. Working from a modest office near Philadelphia, the three laid the foundation for what would grow into one of the world’s leading media and technology companies. "Julian was an extraordinary leader, a brilliant financial mind, and one of the architects of cabl

  $CMCSA
• TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12

  

  PR10:30:00·1h·IndustrialsLow floatPenny stock

  TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12

  TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ), a global leader in disinfection and decontamination solutions, today announced it will reschedule its conference call to report financial results for the third quarter ended September 30, 2026, to Thursday, November 12, 2026 at 4:30 p.m. ET, and will report results after the close of the financial markets that day. The call was originally scheduled to be held today, Friday, November 6, 2026. The Company and its independent auditor require additional time to finalize the review of the Company’s financial statements. To participate in the call by phone, dial (888) 506-0062 approximately five

  $TOMZ
• Associated Bank and Associated Bank Foundation commit $2.1 million across Nebraska and Council Bluffs, Iowa, carrying American National Bank's legacy forward

  

  PR10:11:00·2h·Finance

  Associated Bank and Associated Bank Foundation commit $2.1 million across Nebraska and Council Bluffs, Iowa, carrying American National Bank's legacy forward

  $100,000 donation to The Salvation Army Western Division will support youth programs at the

  $ASB